Bilateral Iris Depigmentation and Ocular Hypotony as End-Stage Manifestations of Untreated Vogt-Koyanagi-Harada Disease.

Miguel Cuevas; Alejandra de-la-Torre; Andrea Córdoba

doi:10.1080/09273948.2017.1320411

Bilateral Iris Depigmentation and Ocular Hypotony as End-Stage Manifestations of Untreated Vogt-Koyanagi-Harada Disease.

Título traducido de la contribución: Despigmentación bilateral del iris e hipotonía ocular como manifestaciones en fase terminal de la enfermedad de Vogt-Koyanagi-Harada no tratada.

Miguel Cuevas
, Alejandra de-la-Torre
, Andrea Córdoba

Producción científica: Contribución a revista › Artículo de Investigación › revisión exhaustiva

4 Citas (Scopus)

Resumen

Propósito: Describir la despigmentación bilateral intensa del iris y la hipotonía ocular persistente como manifestaciones en etapa terminal de la enfermedad de Vogt-Koyanagi-Harada sin tratar. Métodos: Presentamos los hallazgos clínicos y los estudios de diagnóstico realizados para tres pacientes con despigmentación bilateral del iris. Resultados: se diagnosticó la enfermedad de Vogt-Koyanagi-Harada en el estadio recurrente tardío en tres pacientes con despigmentación bilateral severa del iris e hipotonía ocular persistente. Conclusiones: El diagnóstico temprano y el tratamiento de la inflamación son factores cruciales en el resultado clínico de la enfermedad de Vogt-Koyanagi-Harada. Cuando se deja sin diagnosticar y sin tratamiento desde etapas tempranas, se pueden desarrollar despigmentación del iris severa e hipotonía ocular, manifestaciones poco comunes de esta enfermedad.

Título traducido de la contribución	Despigmentación bilateral del iris e hipotonía ocular como manifestaciones en fase terminal de la enfermedad de Vogt-Koyanagi-Harada no tratada.
Idioma original	Inglés estadounidense
Número de artículo	PMID: 28548582
Páginas (desde-hasta)	1-6
Número de páginas	6
Publicación	Ocular Immunology and Inflammation
Fecha en línea anticipada	mar. 26 2017
DOI	https://doi.org/10.1080/09273948.2017.1320411
Estado	Publicada - may. 26 2017

ODS de las Naciones Unidas

Este resultado contribuye a los siguientes Objetivos de Desarrollo Sostenible

ODS 3: Salud y bienestar

Áreas temáticas de ASJC Scopus

Inmulogía y alergología
Oftalmología

Acceder al documento

10.1080/09273948.2017.1320411

Citar esto

@article{cc472211d05347908b1c6b710f87fb2c,

title = "Bilateral Iris Depigmentation and Ocular Hypotony as End-Stage Manifestations of Untreated Vogt-Koyanagi-Harada Disease.",

abstract = "Purpose: To describe severe bilateral iris depigmentation and persistent ocular hypotony as end-stage manifestations of untreated Vogt–Koyanagi–Harada disease. Methods: We present the clinical findings and diagnostic studies performed for three patients with bilateral iris depigmentation. Results: Vogt–Koyanagi–Harada disease in late recurrent stage was diagnosed in three patients with bilateral severe iris depigmentation and persistent ocular hypotony. Conclusions: Early diagnosis and treatment of inflammation are crucial factors in the clinical outcome of Vogt–Koyanagi–Harada disease. When left undiagnosed and untreated from early stages, severe iris depigmentation and ocular hypotony, uncommon manifestations of this disease, can develop.",

author = "Miguel Cuevas and Alejandra de-la-Torre and Andrea C{\'o}rdoba",

year = "2017",

month = may,

day = "26",

doi = "10.1080/09273948.2017.1320411",

language = "English (US)",

pages = "1--6",

journal = "Ocular Immunology and Inflammation",

issn = "0927-3948",

publisher = "Taylor and Francis Ltd.",

}

TY - JOUR

T1 - Bilateral Iris Depigmentation and Ocular Hypotony as End-Stage Manifestations of Untreated Vogt-Koyanagi-Harada Disease.

AU - Cuevas, Miguel

AU - de-la-Torre, Alejandra

AU - Córdoba, Andrea

PY - 2017/5/26

Y1 - 2017/5/26

N2 - Purpose: To describe severe bilateral iris depigmentation and persistent ocular hypotony as end-stage manifestations of untreated Vogt–Koyanagi–Harada disease. Methods: We present the clinical findings and diagnostic studies performed for three patients with bilateral iris depigmentation. Results: Vogt–Koyanagi–Harada disease in late recurrent stage was diagnosed in three patients with bilateral severe iris depigmentation and persistent ocular hypotony. Conclusions: Early diagnosis and treatment of inflammation are crucial factors in the clinical outcome of Vogt–Koyanagi–Harada disease. When left undiagnosed and untreated from early stages, severe iris depigmentation and ocular hypotony, uncommon manifestations of this disease, can develop.

AB - Purpose: To describe severe bilateral iris depigmentation and persistent ocular hypotony as end-stage manifestations of untreated Vogt–Koyanagi–Harada disease. Methods: We present the clinical findings and diagnostic studies performed for three patients with bilateral iris depigmentation. Results: Vogt–Koyanagi–Harada disease in late recurrent stage was diagnosed in three patients with bilateral severe iris depigmentation and persistent ocular hypotony. Conclusions: Early diagnosis and treatment of inflammation are crucial factors in the clinical outcome of Vogt–Koyanagi–Harada disease. When left undiagnosed and untreated from early stages, severe iris depigmentation and ocular hypotony, uncommon manifestations of this disease, can develop.

U2 - 10.1080/09273948.2017.1320411

DO - 10.1080/09273948.2017.1320411

M3 - Research Article

C2 - 28548582

AN - SCOPUS:85019707641

SN - 0927-3948

SP - 1

EP - 6

JO - Ocular Immunology and Inflammation

JF - Ocular Immunology and Inflammation

M1 - PMID: 28548582

ER -

Bilateral Iris Depigmentation and Ocular Hypotony as End-Stage Manifestations of Untreated Vogt-Koyanagi-Harada Disease.

Resumen

ODS de las Naciones Unidas

Áreas temáticas de ASJC Scopus

Acceder al documento

Huella

Citar esto